基于相邻剂量信息的早期完成,用于模型辅助设计,以加快最大耐受剂量的发现
1Biometrics Department, R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
The international journal of biostatistics
|June 3, 2025
概括
这项研究引入了I期试验的早期完成方法,通过使用相邻剂量毒性数据加速最大耐受剂量 (MTD) 识别. 该方法可以更快地准确识别MTD,而不会影响试验结果.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一期临床试验对于确定最大耐受剂量 (MTD) 至关重要.
- 传统的MTD识别可能耗时,延迟后续的试验阶段.
- 模型辅助设计为优化剂量升级策略提供了一个框架.
研究的目的:
- 介绍和评估一种早期完成的方法,以加快在I期试验中的MTD识别.
- 通过模拟和真实临床试验数据,评估该方法对试验结果的准确性和影响.
- 为了证明该方法与模型辅助剂量确定设计的兼容性.
主要方法:
- 开发了一种早期完成方法,利用相邻剂量水平的毒性数据.
- 基于多重剂量信息计算的剂量分配概率.
- 通过模拟和实际临床试验的数据评估了该方法的性能,评估了MTD选择准确性和试验效率.
- 将拟议的方法与MTD识别的标准方法进行了比较.
主要成果:
- 早期完成方法准确地识别了MTD,与标准方法相比,准确性最小.
- 在某些场景中,拟议的方法甚至显示了MTD选择精度的提高.
- 该方法加快了MTD的识别,使得以后的试验阶段的进展更快.
- 早期完成方法与模型辅助设计无集成.
结论:
- 提议的早期完成方法有效地加速了第一阶段试验中MTD的识别.
- 这种方法保持了高精度,甚至可以提高MTD选择精度.
- 当应用到模型辅助设计时,它不会带来任何问题,为临床试验优化提供了有价值的工具.
相关概念视频
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
224
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
224
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
01:28Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
217
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
217
01:21Dose Size and Dosing Frequency: Determination Methods
279
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
279